GlassScriptPhysician profile
Alexis M Mckee
NPI 1144518069
$37,095.86
in general payments reported to CMS, 2019-2025
21 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,193 · 2020: $22K · 2021: $2,874 · 2022: $9,637 · 2023: $383 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,419.56 | 2019-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $10,367.44 | 2019-2023 | Rybelsus, Ozempic |
| Medtronic, INC. | $3,777.14 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,170.23 | 2019-2023 | Jardiance |
| Lilly USA, LLC | $2,322.78 | 2020-2022 | |
| Medtronic Minimed, INC. | $1,343.71 | 2019 | |
| Radius Health, INC. | $152.28 | 2019 | |
| Sequel Med Tech, LLC | $149.27 | 2025 | Twiist |
| Mannkind Corporation | $73.42 | 2019-2022 | |
| Amgen INC. | $61.70 | 2019 | |
| Merck Sharp & Dohme LLC | $43.29 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $37.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.16 | 2019 | |
| Tandem Diabetes Care, INC. | $26.90 | 2019 | |
| Senseonics, Incorporated | $23.00 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amylyx Pharmaceuticals, INC. | $21.67 | 2023 | Relyvrio |
| Astrazeneca Pharmaceuticals LP | $19.64 | 2019 | |
| Ascendis Pharma Endocrinology INC | $16.15 | 2023 | |
| Shire North American Group INC | $13.93 | 2019 | |
| Insulet Corporation | $11.91 | 2019 | |
| Horizon Therapeutics Plc | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.